About Stevanato Group
Stevanato Group is a publicly listed company based in Piombino Dese (Italy) founded in 1949. Pharmaceutical products, wearables, and inhalers are manufactured globally. Its website stevanatogroup.com draws about 81 thousand monthly visits. Stevanato Group offers products and services including Drug Containment Solutions and Drug Delivery Systems. Its focus areas include Traditional Medical Devices.
Company details
Stevanato Group was founded in 1949 in Piombino Dese, Italy, and operates within the pharmaceutical manufacturing sector. Precision glass containers, syringes, and delivery systems for injectable drugs are produced, alongside components for wearables and inhalation devices. Operations span design, production, and supply chain management, with facilities focused on quality standards for medical applications. International distribution supports healthcare and biotech industries from its Italian base.
- Headquarters Piombino Dese, Italy
- Stage Public
- SectorsHealthcare
- Website category Heavy Industry and Engineering · Chemical Industry
- Website stevanatogroup.com/en
- Social LinkedIn X Facebook YouTube
- Legal Name Stevanato Group S.P.A.
- Annual Revenue$1.34 B (USD)12.11as on Dec 31, 2025
- Net Profit$157.82 M (USD)23.88as on Dec 31, 2025
- EBITDA$315.01 M (USD)25.15as on Dec 31, 2025
Products & Services of Stevanato Group
Stevanato Group offers a comprehensive portfolio of products and services, including Drug Containment Solutions and Drug Delivery Systems.
Drug containment solutions are manufactured for glass primary packaging, including vials and syringes, to support the pharmaceutical industry.
Drug delivery systems are developed, including auto-injectors and pen injectors, to facilitate the administration of pharmaceutical products.
Apps and channels of Stevanato Group
its YouTube channel Stevanato Group has 1.45K subscribers and 30 videos.
Videos from Stevanato Group
The most watched videos on Stevanato Group's YouTube channel, Stevanato Group (1.45K subscribers). Click a video to play it here.
More on Stevanato Group.
People of Stevanato Group
237 people are tracked at Stevanato Group (48 in leadership, 9 in board & advisors, 180 in team).
| Name | Role | Group |
|---|---|---|
Paolo Ziero | Engineering Operations Director Italy | Leadership |
Franco Stevanato | Chairman & CEO | Leadership |
Marco Dal Lago | Chief Financial Officer | Leadership |
Marco Pirinoli | Process Engineering Director | Leadership |
Neal Terry | Director Of Business Development DDS | Leadership |
Matthias Meissner | Senior Director Device Operations And Program Management | Leadership |
Giorgia Vavoli | Ez-fill® Production Department Head | Leadership |
Anthony Vico | Head Of Business Line, US Technology Excellence Center | Leadership |
Annika Piile Steen | Head Of Production | Leadership |
Annacristina Mansutti | Vice President, Procurement | Leadership |
Federica Iannello | Director Project Management | Engineering Business Unit | Leadership |
Gioga Alessandro | VP Regional Afc, Americas | Leadership |
Pace Raffaele | President, Engineering Business Unit | Leadership |
Alessandro Dalla Francesca | Global Procurement Manager (head Of Dept) | Leadership |
Simone Grandi | Plant Director | Leadership |
Pierre-Emmanuel Leteurtre | Svp, Global Quality Head | Leadership |
Francesca Todeschini | Head Of PMO And CEO Office | Leadership |
Kennedy Clark | DDS Business Development Director | Leadership |
Céline Delannoy | Compliance, Regulatory, Quality R&d & Corporate Audit Director | Leadership |
Alice Bellini | Director, Quality Validation & Computer System Validation - Drug Containment Solutions | Leadership |
217 more people are available in the full profile.
Complete people profiles for Stevanato Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Stevanato Group
Stevanato Group is a publicly listed company on the NYSE with ticker symbol STVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Jul 2021
- Listed onEuronext: 87N
- Listed entityStevanato Group S.p.A.
- Exchange sectorHealth technology
- ISINIT0005452658
- Share price$19.26 (+0.1% on the day) · 2026-10-13
- Market capitalisation$5.26B
- Price to earnings33.5
- EPS (diluted, trailing year)$0.58
- Dividend yield0.32%
- Volume (last session)398,475
Financials of Stevanato Group
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.34B | $157.8M | $315.0M |
| 2024 | $1.19B | $127.4M | $251.7M |
| 2023 | $1.17B | $157.4M | $290.6M |
| 2022 | $1.03B | $150.1M | $250.6M |
| 2021 | $997.5M | $158.8M | $247.3M |
Detailed financial statements for Stevanato Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Stevanato Group
The website of Stevanato Group (stevanatogroup.com) receives about 80.7K visits a month and ranks #629,252 among all websites worldwide, #9,457 in Chemical Industry.
- Monthly visits80.7K
▲ 66.1% vs previous month
- Unique visitors25.9K
per month
- Global rank#629,252
among all websites
- Category rank#9,457
Heavy Industry and Engineering · Chemical Industry
- Bounce rate47%
- Pages per visit2.3
- Average visit39 sec
- DevicesDesktop 27% · Mobile 73%
Websites whose visitors overlap most with Stevanato Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ompipharma.com | ompipharma.com | 100% | – | ||
divitecsrl.it | divitecsrl.it | 48% | #7,853,183 | – | |
| shibuya.co.jp | 43% | 54.4K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stevanato Group
Complete news archive for Stevanato Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stevanato Group
Stevanato Group was founded in 1949.
Stevanato Group is headquartered in Piombino Dese, Italy. It is registered at Piombino Dese, Veneto, Italy.
Annual revenue of Stevanato Group is $1.34B as on Dec 31, 2025.
Stevanato Group was founded in 1949 in Piombino Dese, Italy, and operates within the pharmaceutical manufacturing sector. Precision glass containers, syringes, and delivery systems for injectable drugs are produced, alongside components for wearables and inhalation devices. Operations span design, production, and supply chain management, with facilities focused on quality standards for medical applications. International distribution supports healthcare and biotech industries from its Italian base.
Stevanato Group offers Drug Containment Solutions and Drug Delivery Systems.
Yes, Stevanato Group is publicly traded on NYSE under the ticker symbol STVN.
Stevanato Group operates through Stevanato Group.